UPTAKE OF NEWER SECOND-LINE DIABETES MEDICATIONS IN REAL-WORLD VULNERABLE POPULATIONS

被引：0
|
作者：
Ogunsanmi, D. [1 ]
Harrison, A. T. [2 ]
Kovesdy, C. P. [1 ]
Surbhi, S. [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN 38163 USA
[2] Rhodes Coll, Memphis, TN 38112 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD112
引用
收藏
页码：S499 / S499
页数：1
相关论文
共 50 条
  • [21] Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study
    Guo, Chuan-Guo
    Jiang, Fang
    Li, Yueyue
    Chen, Yijun
    Wu, Jialin
    Zhang, Shutian
    Leung, Wai K.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (09) : 2263 - 2272
  • [22] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Choice of Second-line Therapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S199 - S199
  • [23] A real-world study of TACE combined with regorafenib as a second-line treatment for advanced hepatocellular carcinoma
    Liu, Shaoxing
    Gao, Song
    Guo, Jianhai
    Kou, Fuxin
    Zhang, Xin
    Liu, Baojiang
    Feng, Aiwei
    Wang, Xiaodong
    Chen, Hui
    Zhu, Xu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study
    Yuxiao Liu
    Xiaofan Guo
    Peijun Xu
    Yuning Song
    Jing Huang
    Xingyun Chen
    Wenbo Zhu
    Jihui Hao
    Song Gao
    Cancer Biology & Medicine, 2024, 21 (09) : 799 - 812
  • [25] Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in England
    Moore, Sally
    Cornic, Laura
    Crossman-Barnes, Christina-Jane
    Jose, Sophie
    Khalaf, Zeyad
    Yong, Kwee
    Soutar, Megan
    Woods, Philip
    EJHAEM, 2025, 6 (01):
  • [26] Using Anlotinib as Second-line and Subsequent Treatments for Advanced Gynecological Malignancies: a Real-world Study
    Wang, Yuping
    Li, Dengke
    Zhang, Yuke
    Liu, Yuese
    Liu, Peimin
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 (07): : 1407 - 1414
  • [27] Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy
    Russano, M.
    Cantini, L.
    B, A. P.
    George, R.
    Nunes, P.
    Tolba, K.
    Dutra, C.
    Chico, I.
    Cortellini, A.
    Pecci, F.
    Alessi, J. V.
    Ricciuti, B.
    Ramkissoon, S.
    Aerts, J. G.
    Agrawal, S.
    Saini, K. S.
    ANNALS OF ONCOLOGY, 2024, 35 : S854 - S854
  • [28] Real-World Effectiveness of Gliclazide MR vs. Sitagliptin as Second-Line Therapy in People with Type 2 Diabetes Uncontrolled on Metformin
    Zaccardi, Francesco
    Cortese, Viviana
    Jacquot, Emmanuelle
    Tyrer, Freya
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES, 2020, 69
  • [29] The Association Between Second-Line Oral Antihyperglycemic Medication on Types of Dementia in Type 2 Diabetes: A Nationwide Real-World Longitudinal Study
    Kim, Won Jun
    Noh, Jung Hyun
    Han, Kyungdo
    Park, Cheol-Young
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 81 (03) : 1263 - 1272
  • [30] Patient Preferences Informing Choice of Second-Line Type 2 Diabetes Medications
    Golembiewski, Elizabeth
    Garcia, Andrea E.
    Polley, Eric
    Umpierrez, Guillermo
    Galindo, Rodolfo J.
    Brito, Juan
    Montori, Victor M.
    Mickelson, Mindy
    Mccoy, Rozalina G.
    DIABETES, 2023, 72
12345